KELLY HALCOMB: Open Payments
NPI 1811933856 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 90 payments from 26 companies in 2025. Trend: 2023 $1,727 · 2024 $1,777 · 2025 $1,708
Food & beverage: $1,708
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $204 |
| PFIZER INC. | 8 | $158 |
| Corcept Therapeutics | 8 | $147 |
| GlaxoSmithKline, LLC. | 7 | $130 |
| Insulet Corporation | 6 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $113 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $91 |
| Novo Nordisk Inc | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
Products named: JARDIANCE, Korlym, Omnipod, CAPLYTA, TRELEGY ELLIPTA, MOUNJARO, ISTURISA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
